F.-D. Boyer, J.-M. Beau et al.
1.5 Hz, H2’), 6.10 (d, 1H, J8b,3a =7.5 Hz, H8b), 3.85 (dq, 1H, J3a,8b =7.5,
3a,6’ =2.6 Hz, H3a), 2.05 (s, 3H, H4c), 2.01 ppm (t, 3H, J7’,3’ =1.5 Hz,
was added acetic anhydride (0.5 mL). The mixture was stirred overnight.
After 12 h, the solvent was evaporated and the crude product was puri-
fied on silica gel (heptane/EtOAc 70:30). Two fractions corresponding to
the 2 epimers were collected in pure form (F1=32b: 27.0 mg, 0.07 mmol,
48%; F2=33b: 25.3 mg, 0.07 mmol, 45%) as amorphous white solids.
(+)-32b: [a]2D6 = +99.6 (c = 2.34, CHCl3); (À)-32b: [a]2D6 = À88.4 (c =
0.7, CHCl3); 1H NMR (300 MHz, CDCl3): d = 7.59 (d, 1H, J6’,3a =2.6 Hz,
H6’), 7.20 (d, 1H, Jar,ar =7.7 Hz, Har), 7.11 (d, 1H, Jar,ar =7.7 Hz, Har),
6.99 (t, 1H, J3’,2’ =J3’,7’ =1.3 Hz, H3’), 6.40 (brs, 1H, H4), 6.16 (d, 1H,
J
H7’); 13C NMR (75 MHz, CDCl3): d = 170.4 (C2 or C4b or C5’), 170.3
(C2 or C4b or C5’), 170.2 (C2 or C4b or C5’), 153.1 (C6’), 141.2 (C3’),
140.7 (C4a or 8a), 140.6 (C4a or C8a), 136.0 (C4’), 130.9 (Car), 130.8
(Car), 126.8 (Car), 126.7 (Car), 109.0 (C3), 100.8 (C2’), 83.9 (C8b), 79.1
(C4), 47.5 (C3a), 21.4 (C4c), 11.0 ppm (C7’); IR (film): n = 2972, 2899,
1781, 1748, 1679, 1372, 1329, 1228, 1080, 863, 744 cmÀ1; MS (ESI): m/z:
379.1 [M+Na]+; HRMS (ESI): m/z: calcd for C19H16O7Na [M+Na]+:
379.0794; found: 379.0806.
J
8b,3a =7.5 Hz, H8b), 6.15 (d, 1H, J2’,3’ =1.3 Hz, H2’), 3.84 (dt, 1H, J3a,8b =
33a: 1H NMR (300 MHz, CDCl3): d = 7.53–7.37 (m, 5H, Har, H6’), 6.96
7.5 Hz, J3a,4 =J3a,6’ =2.6 Hz, H3a), 2.35 (s, 3H, H7a or H8c), 2.28 (s, 3H,
H7a or H8c), 2.03 (brs, 3H, H4c), 2.02 ppm (d, 3H, J7’,3’ =1.3 Hz, H7’);
13C NMR (75 MHz, CDCl3): d = 170.4 (C2, C4b or C5’), 170.3 (C2, C4b
or C5’), 170.1 (C2, C4b or C5’), 152.8 (C6’), 141.2 (C3’), 139.6 (C4’, C4a,
C7, C8 or C8a), 139.5 (C4’, C4a, C7, C8 or C8a), 138.6 (C4’, C4a, C7, C8
or C8a), 135.9 (C4’, C4a, C7, C8 or C8a), 135.7 (C4’, C4a, C7, C8 or
C8a), 132.8 (C5 or C6), 123.5 (C5 or C6), 109.5 (C3), 100.8 (C2’), 83.9
(C8b), 79.6 (C4), 47.4 (C3a), 21.5 (C4c), 19.8 (C7a or C8c), 15.9 (C7a or
C8c), 10.9 ppm (C7’); IR (film): n = 2926, 1785, 1745, 1681, 1372, 1233,
1014, 751 cmÀ1; MS (ESI): m/z: 385.1 [M+H]+; HRMS (ESI): m/z: calcd
for C21H21O7 [M+H]+: 385.1287; found: 385.1287;
(s, 1H, H3’), 6.37 (s, 1H, H4), 6.19 (s, 1H, H2’), 6.09 (d, 1H, J8b,3a
=
7.3 Hz, H8b), 3.86 (brd, 1H, J3a,8b =7.3 Hz, H3a), 2.03 ppm (s, 6H, H4c,
H7’); 13C NMR (75 MHz, CDCl3): d = 170.4 (C2 or C4b or C5’), 170.2
(C2 or C4b or C5’), 170.1 (C2 or C4b or C5’), 151.9 (C6’), 141.0 (C3’),
140.7 (C4a or 8a), 140.6 (C4a or C8a), 136.6 (C4’), 130.8 (Car), 130.7
(Car), 126.9 (Car), 126.5 (Car), 109.2 (C3), 100.2 (C2’), 83.9 (C8b), 79.1
(C4), 47.6 (C3a), 21.3 (C4c), 11.0 ppm (C7’); IR (film): n = 2970, 2900,
1780, 1747, 1680, 1371, 1330, 1227, 1081, 862, 746 cmÀ1; MS (ESI): m/z:
379.1 [M+Na]+; HRMS (ESI): m/z: calcd for C19H16O7Na [M+Na]+:
379.0794; found: 379.0802.
(+)-33b: [a]2D7 = +52.1 (c = 3.11, CHCl3); (À)-33b: [a]2D7 = À52.8 (c =
1.1, CHCl3); 1H NMR (300 MHz, CDCl3): d = 7.48 (d, 1H, J6’,3a =2.4 Hz,
H6’), 7.17 (d, 1H, Jar,ar =7.7 Hz, Har), 7.10 (d, 1H, Jar,ar =7.7 Hz, Har),
Solanacol (6) and 2’-epi-solanacol (30b): Potassium tert-butoxide
(67.9 mg, 0.61 mmol, 2.2 equiv) was added to a mixture of lactone 10b
(60.0 mg, 0.28 mmol, 1 equiv) and ethyl formate (0.23 mL, 2.80 mmol,
10 equiv) in THF (1 mL) at À788C under argon. It was then warmed to
À408C and was stirred for 6 h at this temperature. The mixture was then
cooled to À608C and 9[28] (99.8 mg, 0.56 mmol, 2.05 equiv) was gradually
added. The mixture was then warmed to room temperature. The reaction
was quenched with AcOH (1 mL) after 12 h at this temperature. The sol-
vent was evaporated and the crude product was purified on preparative
TLC (heptane/ethyl acetate 50:50) to afford the two diastereomers as
two pure fractions (F1=30b: 36.0 mg, 0.11 mmol, 38%; F2=6: 36.0 mg,
6.96 (s, 1H, H3’), 6.32 (s, 1H, H4), 6.19 (s, 1H, H2’), 6.14 (d, 1H, J8b,3a
=
7.5 Hz, H8b), 3.84 (d, 1H, J3a,8b =7.5 Hz, H3a), 2.33 (s, 3H, H7a or H8c),
2.26 (s, 3H, H7a or H8c), 2.01 (brs, 3H, H7’), 2.00 ppm (s, 3H, H4c);
13C NMR (75 MHz, CDCl3): d = 170.6 (C2, C4b or C5’), 170.3 (C2, C4b
or C5’), 170.1 (C2, C4b or C5’), 151.5 (C6’), 141.1 (C3’), 139.4 (C4’, C4a,
C7, C8 or C8a), 139.3 (C4’, C4a, C7, C8 or C8a), 138.5 (C4’, C4a, C7, C8
or C8a), 136.4 (C4’, C4a, C7, C8 or C8a), 135.5 (C4’, C4a, C7, C8 or
C8a), 132.7 (C5 or C6), 123.6 (C5 or C6), 109.7 (C3), 100.1 (C2’), 83.9
(C8b), 79.6 (C4), 47.5 (C3a), 21.3 (C4c), 19.8 (C7a or C8c), 15.8 (C7a or
C8c), 11.0 ppm (C7’); IR (film): n = 2924, 1783, 1747, 1682, 1372, 1231,
1015, 750 cmÀ1; MS (ESI): m/z: 385.1 [M+H]+; HRMS (ESI): m/z: calcd
for C21H21O7 [M+H]+: 385.1287; found: 385.1289.
0.11 mmol, 38%) as colorless oils. (À)-(2’S,3aR,4R,8bR,E)-30b: [a]D26
=
À176.4 (c = 1.7, CHCl3); (+)-(2’R,3aS,4S,8bS,E)-30b: [a]2D6 = +178.6 (c
1
= 1, CHCl3); H NMR (300 MHz, CDCl3): d = 7.54 (d, J9,3a =2.6 Hz, 1H,
H9), 7.25 (d, J6,5 =7.7 Hz, 1H, H6), 7.17 (d, J5,6 =7.7 Hz, 1H, H5), 7.00 (t,
Plant assays: Pea rms1 mutant plants (allele rms1–10 identified in the
line Tꢀrꢁse)[40] deficient in SLs were used for the bioassay. The com-
pound to be tested was applied directly to the bud with a micropipette as
10 mL of solution containing 0.1% acetone with 2% polyethylene glycol
1450, 50% ethanol and 0.4% DMSO. 24 plants were sown per treatment
in trays. The treatment was generally done 10 days after sowing, on the
axillary bud at node 4 (or 3). The branches at nodes 1 to 2 were removed
to encourage the outgrowth of axillary buds at nodes above. Nodes were
numbered acropetally from the first scale leaf as node 1 and cotyledonary
node as node 0. Bud growth at node 4 (node 3) was measured 8 to 10
days after treatment with an electronic calliper.
J
3’,2’ =1.5, J3’,7’ =1.5 Hz, 1H, H3’), 6.24 (t, J2’,3’ =1.5, J2’,7’ =1.5 Hz, 1H,
H2’), 6.15 (d, J8b,3a =7.5 Hz, 1H, H8b), 5.27 (d, J4,3a =5.8 Hz, 1H, H4),
3.81 (ddd, J3a,8b =7.5, J3a,4 =5.8, J3a,9 =2.6 Hz, 1H, H3a), 2.37 (s, 3H, H10),
2.31 (s, 3H, H9), 2.08 (d, 1H, OH), 2.05 ppm (t, J7’,2’ =1.5, J7’,3’ =1.5 Hz,
3H, H7’); 13C NMR (75 MHz, CDCl3): d = 171.0 (C2), 170.2 (C5’), 151.5
(C6’), 141.9 (C4a or C8), 141.0 (C3’), 139.0 (C7 or C8a), 138.4 (C7 or
C8a), 136.6 (C4’), 135.7 (C4), 132.9 (C6), 122.5 (C5), 110.9 (C3), 100.7
(C2’), 84.2 (C8b), 80.3 (C4), 50.8 (C3a), 19.8 (C9), 15.8 (C10), 11.1 ppm
(C7’); IR (film): n = 3437, 1780, 1740,1677, 1334, 1186, 1092, 1016,
957 cmÀ1; MS: m/z (%): 365 (100) [M+Na]+, 343 (75) [M+H]+; HRMS
(ESI): m/z: calcd for C19H18NaO6 [M+Na]+: 365.1001; found: 365.1010.
Statistical analyses: Because deviations from normality were observed
for axillary bud length after SL treatment, the Kruskal-Wallis test was
used to assess the significance of treatment in comparison to the control
treatment (0 nm) or to GR24 treatment at the same concentration using
R Commander version 1.7-3.[41]
(À)-(2’R,3aR,4R,8bR,E)-6: [a]D26
=
À164.2 (c
=
2.2, CHCl3); (À)-
(2’S,3aS,4S,8bS,E)-3: [a]D26 = +162.7 (c = 1, CHCl3); H NMR (300 MHz,
CDCl3): d = 7.55 (d, J9,3a =2.6 Hz, 1H, H6’), 7.23 (d, J6,5 =7.7 Hz, 1H,
H6), 7.16 (d, J5,6 =7.7 Hz, 1H, H5), 6.99 (t, J3’,2’ =1.5, J3’,7’ =1.5 Hz, 1H,
H3’), 6.22 (t, J2’,3’ =1.5, J2’,7’ =1.5 Hz, 1H, H2’), 6.15 (d, J8b,3a =7.5 Hz, 1H,
H8b), 5.25 (d, J4,3a =5.8 Hz, 1H, H4), 3.81 (ddd, J3a,8b =7.5, J3a,4 =5.8,
1
J
3a,9 =2.6 Hz, 1H, H3a), 2.37 (s, 3H, H10), 2.30 (s, 3H, H9), 2.06 (d, 1H,
OH), 2.05 ppm (t, J7’,2’ =1.5, J7’,3’ =1.5 Hz, 3H, H6’); 13C NMR (75 MHz,
CDCl3): d = 171.0 (C2), 170.3 (C5’), 151.8 (C6’), 141.9 (C4a or C8), 141.1
(C3’), 138.9 (C7 or C8a), 138.3 (C7 or C8a), 136.4 (C4’), 135.6 (C4), 132.9
(C6), 122.6 (C5), 110.8 (C3), 100.9 (C2’), 84.3 (C8b), 80.2 (C4), 50.6
(C3a), 19.8 (C9), 15.8 (C10), 11.0 ppm (C7’); IR (film): n = 3333, 1781,
1737,1675, 1329, 1183, 953 cmÀ1; MS: m/z (%): 365 (100) [M+Na]+, 343
(75) [M+H]+; HRMS (ESI): m/z: calcd for C19H18NaO6 [M+Na]+:
365.1001; found: 365.1015.
Acknowledgements
The authors thank R. Beau for her comments on the manuscript. We are
grateful to Bayer CropScience (contract no. 08H0120RD), the Institut
Universitaire de France (IUF) and the Centre National de la Recherche
Agronomique (INRA) for the financial support of this study.
(+)-(3aS,4S,8bS,E)-7,8-Dimethyl-3-((((R)-4-methyl-5-oxo-2,5-dihydrofur-
an-2-yl)oxy)methylene)-3,3a,4,8b-tetrahydro-2H-indeno-[1,2-b]furan-4-yl
acetate (32b) and (+)-(3aS,4S,8bS,E)-7,8-dimethyl-3-((((S)-4-methyl-5-
oxo-2,5-dihydrofuran-2-yl)oxy)methylene)-3,3a,4,8b-tetrahydro-2H-
indeno-[1,2-b]furan-4-yl acetate (33b): To a mixture of solanacol 6 and
2’-epi-solanacol 30b (50.0 mg, 0.15 mmol, 1 equiv) in dry pyridine (1 mL)
[1] a) K. Yoneyama, X. Xie, K. Yoneyama, Y. Takeuchi, Pest Manage.
4856
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2013, 19, 4849 – 4857